Coegin Pharma AB (FRA:7Z6)

Market Cap	5.50M -61.6%
Revenue (ttm)	39.11K
Net Income	-1.96M
EPS	-0.08
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,000
Open	0.1710
Previous Close	0.1790
Day's Range	0.1700 - 0.1710
52-Week Range	0.1400 - 0.6600
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 19, 2026

About Coegin Pharma AB

Coegin Pharma AB, a biotechnology company, develops and commercializes cosmetic technologies for hair and skin in Sweden. Its flagship product is Follicopeptide, a patented, clinically developed peptide technology targeting hair thinning; and NPP-4, a cosmetic peptide product designed to enhance skin tone without UV exposure or chemicals. The company also develops FOL026, a peptide drug candidate for the treatment of myocardial infarction; AVX420, a drug candidate for the treatment of leukemia; and AVX001, a drug candidate for the topical treat...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Country: Sweden
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7Z6

Financial Performance

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error